{
    "code": "56025924",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56025924",
    "time": "2019-01-11 04:02:26",
    "許可證字號": "衛部醫器輸字第025924號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "113\/03\/20",
    "發證日期": "103\/03\/20",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05602592401",
    "中文品名": "錄秘帕斯G異常凝血酶原檢驗試劑",
    "英文品名": "Lumipulse G PIVKA-II",
    "效能": "搭配錄秘帕斯G系統，定量測定人類血清中之異常凝血酶原(PIVKA-II)。",
    "醫器規格": "(3 × 14 Tests) \/ Kit。\r\n仿單、標籤變更：詳如中文仿單核定本(原103.4.17核准之仿單、標籤核定本予以回收作廢)。",
    "劑型": "",
    "包裝": "",
    "標籤、仿單及包裝加註": "",
    "": "",
    "醫器主類別一": "C免疫學及微生物學裝置",
    "醫器次類別一": "C6010腫瘤相關抗原免疫試驗系統",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "主成分略述": [
        ""
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "1401804200  台富製藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "M266243000  Fujirebio Inc. Sagamihara Facility",
        "製造廠廠址": "1-3-14,Tanashioda,Chuo-ku,Sagamihara-shi,Kanagawa,252-0245 Japan",
        "製造廠公司地址": "",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560259240001-103-08-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025924&Seq=002&Type=9"
        },
        {
            "title": "560259240001-103-06-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025924&Seq=001&Type=9"
        },
        {
            "title": "560259240001-103-08-26.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025924&Seq=002&Type=8"
        },
        {
            "title": "560259240002--103-06-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025924&Seq=001&Type=8"
        }
    ]
}